Differential effects of wilms tumor WT1 splice variants on the insulin receptor promoter

Biochemical and Molecular Medicine

Volumn 62, Issue 2, 1997, Pages 139-150

  Webster, Nicholas J G ^a   Kong, Yan ^a,b   Sharma, Prem ^a,b   Haas, Martin ^a,b   Sukumar, Saraswati ^c   Seely, B Lynn ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN RECEPTOR;

ARTICLE; DNA BINDING; DNA FOOTPRINTING; EMBRYO DEVELOPMENT; GENE DELETION; GENE MUTATION; KIDNEY DEVELOPMENT; MOLECULAR CLONING; NEPHROBLASTOMA; NONHUMAN; PROMOTER REGION; PROTEIN DOMAIN;

EID: 0031404951     PISSN: 10773150     EISSN: None     Source Type: Journal    
DOI: 10.1006/bmme.1997.2648     Document Type: Article

References (40)

1. Call K M, Glaser T, Ito C Y, Buckler A J, Pelletier J, Haber D A, Rose E A, Kral A, Yeger H, Lewis W H. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell. 60:1990;509-520.
2. Glaser T, Lane J, Housman D. A mouse model of the aniridia-Wilms tumor deletion syndrome. Science. 250:1990;823-827.
3. Pelletier J, Bruening W, Kashtan C E, Mauer S M, Manivel J C, Striegel J E, Houghton D C, Junien C, Habib R, Fouser L. Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell. 67:1991;437-447.
4. Sharma P M, Yang X, Bowman M, Roberts V, Sukumar S. Molecular cloning of rat Wilms' tumor complementary DNA and a study of messenger RNA expression in the urogenital system and the brain. Cancer Res. 52:1992;6407-6412.
5. Kreidberg J A, Sariola H, Loring J M, Maeda M, Pelletier J, Housman D, Jaenisch R. WT-1 is required for early kidney development. Cell. 74:1993;679-691.
6. Englert C, Hou X, Maheswaran S, Bennett P, Ngwu C, Re G G, Garvin A J, Rosner M R, Haber D A. WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis. EMBO J. 14:1995;4662-4675.
7. Madden S L, Cook D M, Morris J F, Gashler A, Sukhatme V P, Rauscher F J III. Transcriptional repression mediated by the WT1 Wilms tumor gene product. Science. 253:1991;1550-1553.
8. Dey B R, Sukhatme V P, Roberts A B, Sporn M B, Rauscher F J, Kim S J. Repression of the transforming growth factor-beta 1 gene by the Wilms' tumor suppressor WT1 gene product. Mol Endocrinol. 8:1994;595-602.
9. Harrington M A, Konicek B, Song A, Xia X L, Fredericks W J, Rauscher F J. Inhibition of colony-stimulating factor-1 promoter activity by the product of the Wilms' tumor locus. J Biol Chem. 268:1993;21271-21275.
10. Werner H, Re G G, Drummond I A, Sukhatme V P, Rauscher F J, Sens D A, Garvin A J, LeRoith D, Roberts C TJ. Increased expression of the insulin-like growth factor I receptor gene, IGFIR, in Wilm's tumor is correlated with modulation ofIGFIRWT1. Proc Natl Acad Sci USA. 90:1993;5828-5832.
11. Gashler A L, Bonthron D T, Madden S L, Rauscher F J, Collins T, Sukhatme V P. Human platelet-derived growth factor A chain is transcriptionally repressed by the Wilms tumor suppressor WT1. Proc Natl Acad Sci USA. 89:1992;10984-10988.
12. Drummond I A, Madden S L, Rohwer-Nutter P, Bell G I, Sukhatme V P, Rauscher F J. Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1. Science. 257:1992;674-678.
13. Goodyer P, Dehbi M, Torban E, Bruening W, Pelletier J. Repression of the retinoic acid receptor-alpha gene by the Wilms' tumor suppressor gene product, wt1. Oncogene. 10:1995;1125-1129.
14. Sharma P M, Bowman M, Yu B F, Sukumar S. A rodent model for Wilms tumors: Embryonal kidney neoplasms induced byNN. Proc Natl Acad Sci USA. 91:1994;9931-9935.
15. Werner H, Shen-Orr Z, Rauscher F J, Morris J F, Roberts C TJ, LeRoith D. Inhibition of cellular proliferation by the Wilms' tumor suppressor WT1 is associated with suppression of insulin-like growth factor I receptor gene expression. Mol Cell Biol. 15:1995;3516-3522.
16. Haber D A, Sohn R L, Buckler A J, Pelletier J, Call K M, Housman D E. Alternative splicing and genomic structure of the Wilms tumor gene WT1. Proc Natl Acad Sci USA. 88:1991;9618-9622.
17. Sharma P M, Bowman M, Madden S L, Rauscher F J, Sukumar S. RNA editing in the Wilms' tumor susceptibility gene, WT1. Genes Dev. 8:1994;720-731.
18. Rauscher F J, Morris J F, Tournay O E, Cook D M, Curran T. Binding of the Wilms' tumor locus zinc finger protein to the EGR-1 consensus sequence. Science. 250:1990;1259-1262.
19. Drummond I A, Rupprecht H D, Rohwer-Nutter P, Lopez-Guisa J M, Madden S L, Rauscher F J, Sukhatme V P. DNA recognition by splicing variants of the Wilms' tumor suppressor, WT1. Mol Cell Biol. 14:1994;3800-3809.
20. Nakagama H, Heinrich G, Pelletier J, Housman D E. Sequence and structural requirements for high-affinity DNA binding by the WT1 gene product. Mol Cell Biol. 15:1995;1489-1498.
21. Hamilton T B, Barilla K C, Romaniuk P J. High affinity binding sites for the Wilms' tumour suppressor protein WT1. Nucleic Acids Res. 23:1995;277-284.
22. Madden S L, Cook D M, Rauscher F J. A structure-function analysis of transcriptional repression mediated by the WT1, Wilms' tumor suppressor protein. Oncogene. 8:1993;1713-1720.
23. Wang Z Y, Qiu Q Q, Huang J, Gurrieri M, Deuel T F. Products of alternatively spliced transcripts of the Wilms' tumor suppressor gene, wt1, have altered DNA binding specificity and regulate transcription in different ways. Oncogene. 10:1995;415-422.
24. Wang Z Y, Qiu Q Q, Gurrieri M, Huang J, Deuel T F. WT1, the Wilms' tumor suppressor gene product, represses transcription through an interactive nuclear protein. Oncogene. 10:1995;1243-1247.
25. Liu Z Z, Kumar A, Ota K, Wallner E I, Kanwar Y S. Developmental regulation and the role of insulin and insulin receptor in metanephrogenesis. Proc Natl Acad Sci USA. 94:1997;6758-6763.
26. McKeon C, Moncada V, Pham T, Salvatore P, Kadowaki T, Accili D, Taylor S I. Structural and functional analysis of the insulin receptor promoter. Mol Endocrinol. 4:1990;647-656.
27. Mamula P W, Wong K Y, Maddux B A, McDonald A R, Goldfine I D. Sequence and analysis of promoter region of human insulin-receptor gene. Diabetes. 37:1988;1241-1246.
28. Tewari D S, Cook D M, Taub R. Characterization of the promoter region and 3′ end of the human insulin receptor gene. J Biol Chem. 264:1989;16238-16245.
29. Cameron K E, Resnik J, Webster N J. Transcriptional regulation of the human insulin receptor promoter. J Biol Chem. 267:1992;17375-17383.
30. Levy J R, Hug V. Nuclear protein-binding analysis of a GC-rich insulin-receptor promoter regulatory region. Diabetes. 42:1993;66-73.
31. Lee J K, Tam J W, Tsai M J, Tsai S Y. Identification of cis- and trans-acting factors regulating the expression of the human insulin receptor gene. J Biol Chem. 267:1992;4638-4645.
32. Webster N JG, Kong Y, Cameron K E, Resnik J L. An upstream element from the human insulin receptor gene promoter contains binding sites for C/EBPβ and NF-1. Diabetes. 43:1994;305-312.
33. McKeon C, Pham T. Transactivation of the human insulin receptor gene by the CAAT/enhancer binding protein. Biochem Biophys Res Commun. 174:1991;721-728.
34. Webster N JG, Resnik J L, Reichart D B, Strauss B, Haas M, Seely B L. Repression of the insulin receptor promoter by the tumor suppressor gene product p53: A possible mechanism for receptor overexpression in breast cancer. Cancer Res. 56:1996;2781-2788.
35. Maheswaran S, Park S, Bernard A, Morris J F, Rauscher F J, Hill D E, Haber D A. Physical and functional interaction between WT1 and p53 proteins. Proc Natl Acad Sci USA. 90:1993;5100-5104.
36. Drummond I A, Rupprecht H D, Rohwer-Nutter P, Lopez-Guisa J M, Madden S L, Rauscher F J III, Sukhatme V P. DNA recognition by splicing variants of the Wilms' tumor suppressor, WT1. Mol Cell Biol. 14:1994;3800-3809.
37. Bickmore W A, Oghene K, Little M H, Seawright A, Van Heyningen V, Hastie N D. Modulation of DNA binding specificity by alternative splicing of the Wilms tumor wt1 gene transcript. Science. 257:1992;235-237.
38. Englert C, Vidal M, Maheswaran S, Ge Y, Ezzell R M, Isselbacher K J, Haber D A. Truncated WT1 mutants alter the subnuclear localization of the wild-type protein. Proc Natl Acad Sci USA. 92:1995;11960-11964.
39. Larsson S H, Charlieu J P, Miyagawa K, Engelkamp D, Rassoulzadegan M, Ross A, Cuzin F, Van Heyningen V, Hastie N D. Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing. Cell. 81:1995;391-401.
40. Maheswaran S, Englert C, Bennett P, Heinrich G, Haber D A. The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis. Genes Dev. 9:1995;2143-2156.